$QTRX

Quanterix Corp

CIK:0001503274|SEC Filings

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues:
Total revenues	$ 32,906	$ 24,476	$ 69,322	$ 54,810
Costs of goods sold and services:
Total costs of goods sold and services	20,232	14,475	41,081	29,970
Gross profit	12,674	10,001	28,241	24,840
Operating expenses:
Research and development	7,821	9,081	15,144	19,117
Selling, general and administrative	27,350	30,350	57,121	61,520
Impairment and restructuring costs	26,934	7,670	46,769	7,670
Total operating expenses	62,105	47,101	119,034	88,307
Loss from operations	(49,431)	(37,100)	(90,793)	(63,467)
Other income (expense), net:
Interest income	761	2,692	1,653	5,962
Change in fair value of contingent liabilities	(79)	4,273	1,422	3,894
Other income (expense), net	(239)	49	21,182	108
Loss before income taxes	(48,988)	(30,086)	(66,536)	(53,503)
Income tax benefit	54	73	61	2,986
Net loss	$ (48,934)	$ (30,013)	$ (66,475)	$ (50,517)
Net loss per common share, basic (in dollars per share)	$ (1.04)	$ (0.77)	$ (1.41)	$ (1.30)
Net loss per common share, diluted (in dollars per share)	$ (1.04)	$ (0.77)	$ (1.41)	$ (1.30)
Weighted-average common shares outstanding, basic (in shares)	47,167	38,893	47,068	38,801
Weighted-average common shares outstanding, diluted (in shares)	47,167	38,893	47,068	38,801
Product revenue
Revenues:
Total revenues	$ 23,476	$ 16,832	$ 48,956	$ 37,572
Costs of goods sold and services:
Total costs of goods sold and services	14,621	10,594	29,761	21,935
Service and other revenue
Revenues:
Total revenues	9,018	7,112	19,394	15,935
Costs of goods sold and services:
Total costs of goods sold and services	5,611	3,881	11,320	8,035
Collaboration and license revenue
Revenues:
Total revenues	$ 412	$ 532	$ 972	$ 1,303

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (66,475)	$ (50,517)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	11,737	4,187
Credit losses on accounts receivable	516	(262)
Accretion of marketable securities	(202)	(1,567)
Operating lease right-of-use asset amortization	1,601	850
Stock-based compensation expense	8,739	10,834
Impairment	46,769	6,374
Change in fair value of contingent liabilities	(1,422)	(3,894)
Recognition of off-market liability	(13,975)	0
Other operating activity	(558)	(370)
Changes in assets and liabilities:
Accounts receivable	6,817	9,476
Inventory	7,652	2,993
Prepaid expenses and other current assets	1,561	1,942
Accounts payable	(6,763)	2,796
Accrued compensation and benefits, accrued expenses, and other current liabilities	(6,377)	1,605
Deferred revenue	(9,163)	583
Net change in other operating assets and liabilities	(3,683)	(4,573)
Net cash used in operating activities	(23,226)	(19,543)
Cash flows from investing activities:
Purchases of marketable securities	(8,245)	(30,245)
Proceeds from sales and maturities of marketable securities	47,354	135,874
Purchases of property and equipment	(183)	(2,033)
Acquisitions, net of cash acquired	0	(8,954)
Net cash provided by investing activities	38,926	94,642
Cash flows from financing activities:
Deferred acquisition payments	(1,439)	0
Principal payments on financing leases	(171)	0
Proceeds from common stock issued under stock plans	340	668
Payments for employee taxes withheld on stock-based compensation awards	(27)	(1,004)
Net cash used in financing activities	(1,297)	(336)
Net increase in cash, cash equivalents, and restricted cash	14,403	74,763
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(66)	1,455
Cash, cash equivalents, and restricted cash at beginning of period	33,180	59,319
Cash, cash equivalents, and restricted cash at end of period	$ 47,517	$ 135,537

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 44,169	$ 29,839
Marketable securities	49,360	88,393
Accounts receivable, net of allowance for expected credit losses	22,345	29,972
Inventory	47,601	54,763
Prepaid expenses and other current assets	7,576	9,290
Total current assets	171,051	212,257
Restricted cash	3,348	3,341
Property and equipment, net	20,002	23,672
Intangible assets, net	105,782	131,787
Goodwill	0	26,376
Operating lease right-of-use assets	15,053	16,664
Other non-current assets	4,391	4,669
Total assets	319,627	418,766
Current liabilities:
Accounts payable	8,892	13,568
Accrued compensation and benefits	10,293	14,979
Accrued expenses and other current liabilities	8,483	17,571
Deferred revenue	14,892	20,728
Operating lease liabilities	7,813	7,916
Total current liabilities	50,373	74,762
Deferred revenue, net of current portion	2,502	5,830
Operating lease liabilities, net of current portion	25,574	29,323
Non-current portion of contingent liabilities	3,265	5,024
Other non-current liabilities	701	8,097
Total liabilities	82,415	123,036
Commitments and contingencies (Note 15)
Stockholders’ equity:
Common stock: $0.001 par value; Authorized: 120,000; Issued and outstanding: 47,135 and 46,744 shares at June 30, 2026 and December 31, 2025, respectively	47	47
Additional paid-in capital	882,039	873,637
Accumulated other comprehensive loss	(1,168)	(723)
Accumulated deficit	(643,706)	(577,231)
Total stockholders’ equity	237,212	295,730
Total liabilities and stockholders’ equity	$ 319,627	$ 418,766